Lexapro (escitalopram oxalate) Tablets Oral Solution NDA[removed]NDA[removed]Proposed Labeling Text Lexapro® - Reuptake - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2009-03-31 14:51:03 Selective serotonin reuptake inhibitors Medicine Nitriles Amines Escitalopram Citalopram Serotonin–norepinephrine reuptake inhibitor Antidepressant Pimozide Chemistry Organic chemistry Organofluorides		Lexapro (escitalopram oxalate) Tablets/Oral Solution NDA[removed]NDA[removed]Proposed Labeling Text Lexapro® Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 208,64 KB Share Document on Facebook

	Microsoft Word - 14B006-XTA-WPI.doc DocID: 19OD0 - View Document
	\|A\| A ABC of general practice Its nature and content DocID: 18Suo - View Document
	----------------------- WARNINGS AND PRECAUTIONS ---------------------- • Hematologic: Neutropenia may occur. Monitor complete blood count prior to start of IBRANCE therapy and at the beginning of each cycle, as wel DocID: 18Pzx - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Tasigna safely and effectively. See full prescribing information for Tasigna. Tasigna® (nilotinib) Capsules Initial DocID: 18Mfy - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYKADIA safely and effectively. See full prescribing information for ZYKADIA. ZYKADIA™ (ceritinib) capsules, for o DocID: 18KFt - View Document